+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Investigation Report on China's Leuprorelin Market 2021-2025

  • ID: 5345899
  • Report
  • June 2021
  • Region: China
  • China Research & Intelligence
Leuprolide is a synthetic gonadotropin drug used to treat hormone-responsive cancers such as prostate cancer and breast cancer. It can also be used to treat precocious puberty and prevent premature ovulation during in vitro fertilization. Leuprolide was patented in 1973 and approved for medical use in the United States in 1985. In 1992, it obtained the license for importing medicine from China. By the first half of 2021, the manufactures in China's leuprolide market are Takeda Pharmaceutical Co., Ltd., Shanghai Livzon Pharmaceutical Co., Ltd., and Beijing Biote Pharmaceutical Co., Ltd.





According to the market research, the sales value of Leuprorelin in the Chinese market increased rapidly year by year from 2016 to 2019. Due to the impact of the COVID-19 epidemic on the hospital's overall diagnosis and treatment services, the growth rate of sales value decreased from 21.01% in 2019 to 11.11% in 2020. The sales value of Leuprorelin in the Chinese market reached CNY1108 million in 2020 and the CAGR was 15.1% in 2016 to 2020.

The analyst expects that with the alleviation of the COVID-19 epidemic, sales of Leuprorelin will have a restorative growth from 2021 to 2025. On August 10, 2020, Shanghai-Takeda China announced that its 3-month dosage form (specification: 11.25mg) of Innate was officially approved by the China National Medical Products Administration for the treatment of Central Precocious Puberty (CPP). This is the third indication approved in China for the 3-month dosage form of Innate. The sales volume of leuprolide is expected to increase with the increase in the number of indications, and there is room for sales to increase.

Topics Covered:

  • The impact of COVID-19 on China's Leuprorelin market
  • Sales value of China's Leuprorelin 2016-2020
  • Competitive landscape of China's Leuprorelin market
  • Prices of Leuprorelin in China
  • Prices of Leuprorelin in China by regions and manufacturers
  • Analysis of factors affecting the development of China's Leuprorelin market
  • Prospect of China's Leuprorelin market from 2021 to 2025
Frequently Asked Questions about the Chinese Leuprorelin Market

What is the estimated value of the Chinese Leuprorelin Market?

The Chinese Leuprorelin Market was estimated to be valued at ¥631.1 Million in 2016.

What is the growth rate of the Chinese Leuprorelin Market?

The growth rate of the Chinese Leuprorelin Market is 15.1%, with an estimated value of ¥2228.1 Million by 2025.

What is the forecasted size of the Chinese Leuprorelin Market?

The Chinese Leuprorelin Market is estimated to be worth ¥2228.1 Million by 2025.

Who are the key companies in the Chinese Leuprorelin Market?

Key companies in the Chinese Leuprorelin Market include Takeda Pharmaceutical Co., Ltd. and Beijing Biote Pharmaceutical Co., Ltd..
Note: Product cover images may vary from those shown

1 Relevant Concepts of Leuprorelin
1.1 Indications for Leuprorelin
1.2 Development of Leuprorelin in China
1.3 Governmental Approval of Leuprorelin in China
1.4 The Impact of COVID-19 on Leuprorelin Sales in China

2 Sales of Leuprorelin in China, 2016-2020
2.1 Sales Value of Leuprorelin
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Leuprorelin
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Leuprorelin by Dosage Form in China, 2016-2020
2.3.1 Microsheres for Injection
2.3.2 Analysis of Other Dosage Form

3 Analysis of Major Leuprorelin Manufacturers in China in 2020
3.1 Analysis of Market Share of Major Leuprorelin Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Takeda Pharmaceutical Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of ENANTONE (Takeda Pharmaceutical Co., Ltd.’s Leuprorelin) in China
3.3 Shanghai Livzon Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Beiyi (Shanghai Livzon Pharmaceutical Co., Ltd.'s Leuprorelin) in China
3.4 Beijing Biote Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Boennuokang (Beijing Biote Pharmaceutical Co., Ltd.’s Leuprorelin) in China

4 Prices of Leuprorelin for Different Manufacturers in China, 2020-2021
4.1 Takeda Pharmaceutical Co., Ltd. (ENANTONE)
4.2 Shanghai Livzon Pharmaceutical Co., Ltd. (Beiyi)
4.3 Beijing Biote Pharmaceutical Co., Ltd. (Boennuokang)

5 Prospect of Chinese Leuprorelin Market, 2021-2025
5.1 Influential Factors of Chinese Leuprorelin Market Development
5.1.1 The Impact of COVID-19 on Chinese Leuprorelin Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information About Leuprorelin Microsheres for Injection Registration in China
Chart Sales Value of Leuprorelin Microsheres for Injection over the World
Chart Sales Value of Leuprorelin Microsheres for Injection in China, 2016-2020
Chart Sales Value of Leuprorelin Microsheres for Injection in China by Region, 2016-2020
Chart Sales Volume of Leuprorelin Microsheres for Injection in China, 2016-2020
Chart Sales Volume of Leuprorelin Microsheres for Injection in China by Region, 2016-2020
Chart Market Share by Sales Value of Top Leuprorelin Microsheres for Injection Manufacturers in China, 2016-2020
Chart Sales Value and Volume of ENANTONE in China, 2016-2020
Chart Sales Value and Volume of Beiyi in China, 2016-2020
Chart Sales Value and Volume of Boennuokang in China, 2016-2020
Chart Referential Prices of ENANTONE in China by Region, 2020-2021
Chart Referential Prices of Beiyi in China by Region, 2020-2021
Chart Referential Prices of Boennuokang in China by Region, 2020-2021
Chart Forecast on Sales Value of Leuprorelin Microsheres for Injection in China, 2021-2025
Chart Forecast on Sales Volume of Leuprorelin Microsheres for Injection in China, 2021-2025


Note: Product cover images may vary from those shown

Loading
LOADING...

  • Takeda Pharmaceutical Co., Ltd.
  • Shanghai Livzon Pharmaceutical Co., Ltd.
  • Beijing Biote Pharmaceutical Co., Ltd.
Note: Product cover images may vary from those shown

Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.

Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.

Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.

The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.

The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.

1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.


 

Loading
LOADING...